CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Trelagliptin

曲格列汀 杂质对照品Trelagliptin Impurities

35 个杂质条目35 impurity entries

本页汇总 曲格列汀 的 35 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 35 impurity reference standards of Trelagliptin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 曲格列汀(Trelagliptin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2018 · Luo Z et al.  ·  PMID 29066384  ·  DOI
  2. 杂质研究Impurity studiesDifferent Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product
    Journal of analytical methods in chemistry · 2018 · Mowaka S et al.  ·  PMID 29629213  ·  DOI
  3. 杂质研究Impurity studiesIdentification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds
    Journal of pharmaceutical and biomedical analysis · 2016 · Zhang H et al.  ·  PMID 27209451  ·  DOI
  4. 分析方法Analytical MethodsA rapid and sensitive UHPLC-MS/MS assay for the determination of trelagliptin in rat plasma and its application to a pharmacokinetic study
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2016 · Hu XX et al.  ·  PMID 27561183  ·  DOI
  5. 分析方法Analytical MethodsAn HPLC-MS/MS method for quantitation of trelagliptin and application in a comparative pharmacokinetic study
    Bioanalysis · 2019 · Han Y et al.  ·  PMID 31648536  ·  DOI

曲格列汀 —— 原料药与杂质对照品Trelagliptin — drug substance & impurities

共 36 个条目(含原料药本体)36 items incl. the drug substance
Trelagliptin structure
原料药 APIAPI
曲格列汀Trelagliptin
Trelagliptin
CAS No.865759-25-7
Chemical FormulaC18H20FN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 1 Succinate structure
1
曲格列汀杂质1琥珀酸盐Trelagliptin Impurity 1 Succinate
Trelagliptin Impurity 1 Succinate
CAS No.2721223-27-2
Chemical FormulaC18H20FN5O2·n(C4H6O4)
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 3 structure
3
曲格列汀杂质3Trelagliptin Impurity 3
Trelagliptin Impurity 3
CAS No.1938080-44-4
Chemical FormulaC18H22FN5O3
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 4 structure
4
曲格列汀杂质4Trelagliptin Impurity 4
Trelagliptin Impurity 4
CAS No.1917324-15-2
Chemical FormulaC18H21FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 5 structure
5
曲格列汀杂质5Trelagliptin Impurity 5
Trelagliptin Impurity 5
CAS No.1917324-13-0
Chemical FormulaC31H28F2N8O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 7 structure
7
曲格列汀杂质7Trelagliptin Impurity 7
Trelagliptin Impurity 7
CAS No.2514948-22-0
Chemical FormulaC18H13ClFN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 9 structure
9
曲格列汀杂质9Trelagliptin Impurity 9
Trelagliptin Impurity 9
CAS No.2204313-59-5
Chemical FormulaC23H24FN7O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 10 structure
10
曲格列汀杂质10Trelagliptin Impurity 10
Trelagliptin Impurity 10
CAS No.2412663-46-6
Chemical FormulaC26H24F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 15 structure
15
曲格列汀杂质15Trelagliptin Impurity 15
Trelagliptin Impurity 15
CAS No.2087874-92-6
Chemical FormulaC22H24FN5O5
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 16 structure
16
曲格列汀杂质16Trelagliptin Impurity 16
Trelagliptin Impurity 16
CAS No.2087874-94-8
Chemical FormulaC40H42F2N10O6
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 20 structure
20
曲格列汀杂质20Trelagliptin Impurity 20
Trelagliptin Impurity 20
CAS No.1938080-43-3
Chemical FormulaC15H14FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 22 structure
22
曲格列汀杂质22Trelagliptin Impurity 22
Trelagliptin Impurity 22
CAS No.865759-24-6
Chemical FormulaC13H9ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 23 structure
23
曲格列汀杂质23Trelagliptin Impurity 23
Trelagliptin Impurity 23
CAS No.2468009-93-8
Chemical FormulaC10H9ClN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 24 structure
24
曲格列汀杂质24Trelagliptin Impurity 24
Trelagliptin Impurity 24
CAS No.1917324-14-1
Chemical FormulaC23H31N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 28 structure
28
曲格列汀杂质28Trelagliptin Impurity 28
Trelagliptin Impurity 28
CAS No.1971613-57-6
Chemical FormulaC13H16FN3
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 31 structure
31
曲格列汀杂质31Trelagliptin Impurity 31
Trelagliptin Impurity 31
CAS No.1821400-07-0
Chemical FormulaC21H13ClF2N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 35 structure
35
曲格列汀杂质35Trelagliptin Impurity 35
Trelagliptin Impurity 35
CAS No.31737-09-4
Chemical FormulaC5H5ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 47 structure
47
曲格列汀杂质47Trelagliptin Impurity 47
Trelagliptin Impurity 47
CAS No.2518282-91-0
Chemical FormulaC13H9ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 49 structure
49
曲格列汀杂质49Trelagliptin Impurity 49
Trelagliptin Impurity 49
CAS No.1000339-93-4
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 50 structure
50
曲格列汀杂质50Trelagliptin Impurity 50
Trelagliptin Impurity 50
CAS No.4270-27-3
Chemical FormulaC4H3ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 54 structure
54
曲格列汀杂质54Trelagliptin Impurity 54
Trelagliptin Impurity 54
CAS No.2514681-74-2
Chemical FormulaC18H20FN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 55 structure
55
曲格列汀杂质55Trelagliptin Impurity 55
Trelagliptin Impurity 55
CAS No.865759-02-0
Chemical FormulaC17H20BrFN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 59 structure
59
曲格列汀杂质59Trelagliptin Impurity 59
Trelagliptin Impurity 59
CAS No.452-63-1
Chemical FormulaC7H6BrF
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 60 structure
60
曲格列汀杂质60Trelagliptin Impurity 60
Trelagliptin Impurity 60
CAS No.112399-50-5
Chemical FormulaC7H5Br2F
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 61 structure
61
曲格列汀杂质61Trelagliptin Impurity 61
Trelagliptin Impurity 61
CAS No.334618-07-4
Chemical FormulaC5H12N2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 61 Monomer structure
61
曲格列汀杂质61 单体Trelagliptin Impurity 61 Monomer
Trelagliptin Impurity 61 Monomer
CAS No.80918-66-7
Chemical FormulaC5H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 65 structure
65
曲格列汀杂质65Trelagliptin Impurity 65
Trelagliptin Impurity 65
CAS No.2836320-76-2
Chemical FormulaC36H39FN10O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 70 structure
70
曲格列汀杂质70Trelagliptin Impurity 70
Trelagliptin Impurity 70
CAS No.2087874-91-5
Chemical FormulaC19H20FN5O3
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 75 structure
75
曲格列汀杂质75Trelagliptin Impurity 75
Trelagliptin Impurity 75
CAS No.2384640-00-8
Chemical FormulaC5H4Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 80 structure
80
曲格列汀杂质80Trelagliptin Impurity 80
Trelagliptin Impurity 80
CAS No.1261742-22-6
Chemical FormulaC8H5ClFN
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 81 structure
81
曲格列汀杂质81Trelagliptin Impurity 81
Trelagliptin Impurity 81
CAS No.295803-26-8
Chemical FormulaC7H4Br3F
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 89 structure
89
曲格列汀杂质89Trelagliptin Impurity 89
Trelagliptin Impurity 89
CAS No.934012-92-7
Chemical FormulaC10H10FNO
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 91 structure
91
曲格列汀杂质91Trelagliptin Impurity 91
Trelagliptin Impurity 91
CAS No.227609-85-0
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 93 structure
93
曲格列汀杂质93Trelagliptin Impurity 93
Trelagliptin Impurity 93
CAS No.1799608-63-1
Chemical FormulaC23H28FN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 96 structure
96
曲格列汀杂质96Trelagliptin Impurity 96
Trelagliptin Impurity 96
CAS No.1882199-16-7
Chemical FormulaC16H9FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Trelagliptin Impurity 97 structure
97
曲格列汀杂质97Trelagliptin Impurity 97
Trelagliptin Impurity 97
CAS No.2204313-60-8
Chemical FormulaC36H39FN10O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

曲格列汀 —— 研究文献与合成路线Trelagliptin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 曲格列汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Trelagliptin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds
    Zhang H, Sun L, Zou L, et al. · Journal of pharmaceutical and biomedical analysis · 2016 · 被引 13cited 13
  2. Suitability of various chromatographic and spectroscopic techniques for analysis and kinetic degradation study of trelagliptin
    Zaghary WA, Mowaka S, Hassan MA, et al. · Scientific reports · 2017 · 被引 6cited 6
  3. Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product
    Mowaka S, Ayoub BM, Hassan MA, et al. · Journal of analytical methods in chemistry · 2018 · 被引 2cited 2
  4. Development of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms
    Luo Z, Chen X, Wang G, et al. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2018 · 被引 8cited 8

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

曲格列汀 杂质谱研究要点Trelagliptin — impurity profiling notes

下面这些是拿到 曲格列汀 的 36 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 36 impurity entries for Trelagliptin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances